TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31042154

Group type: EXPERIMENTAL
Intervention: Mobile prenatal care app
Number of subjects: 88

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 88
Study: 28245151

Group type: EXPERIMENTAL
Intervention: Part-solid nodules
Number of subjects: 19
Study: 26181019

Group type: EXPERIMENTAL
Intervention: More optimistic message video
Number of subjects: 100

Group type: COMPARATOR
Intervention: Less optimistic message video
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sequence effect of video order
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Trust in medical profession after viewing messages
Number of subjects: 100
Study: 23240909

Group type: EXPERIMENTAL
Intervention: One dose of AS03‐adjuvanted A/California/7/2009 (H1N1) vaccine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Two doses of AS03‐adjuvanted A/California/7/2009 (H1N1) vaccine
Number of subjects: 42
Study: 20860765

Group type: EXPERIMENTAL
Intervention: Application of a tongue protector (group B)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Informed therapy (group A)
Number of subjects: 65
Study: 19531054

Group type: EXPERIMENTAL
Intervention: Repaglinide/metformin FDC BID
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Repaglinide/metformin FDC TID
Number of subjects: 561
Study: 17327813

Group type: EXPERIMENTAL
Intervention: Intranasal midazolam (0.1 mg/kg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Intravenous diazepam (titrated doses)
Number of subjects: 34
Study: 15450558

Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 82

Group type: COMPARATOR
Intervention: Normal Saline
Number of subjects: 82
Study: 12043873

Group type: EXPERIMENTAL
Intervention: Epinephrine pellets (Racellet pellets)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20% ferric sulfate (Viscostat)
Number of subjects: 0
Study: 9718615

Group type: EXPERIMENTAL
Intervention: Interferential currents (IFCs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Logistic regression models
Number of subjects: 0
Study: 7529155

Group type: EXPERIMENTAL
Intervention: Washing whole blood samples or blocking with mouse immunoglobulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plasma, serum, or immunoglobulin preparations from donors
Number of subjects: 0
Study: 2626955

Group type: EXPERIMENTAL
Intervention: Acetazolamide 250 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 823405

Group type: EXPERIMENTAL
Intervention: Cortisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 31397726

Group type: EXPERIMENTAL
Intervention: ChildCARE intervention (caregiver intervention with five 2-hour sessions)
Number of subjects: 790

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 790
Study: 27284868

Group type: EXPERIMENTAL
Intervention: Tailored ergonomics advice according to the stage of change (SOC) approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard ergonomics advice
Number of subjects: 0
Study: 25465291

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA) for 20 min with 3Back training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham tDCS with 3Back training
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA) for 20 min with 1Back training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham tDCS with 1Back training
Number of subjects: 22
Study: 23481666

Group type: EXPERIMENTAL
Intervention: Plasma concentrations of lipopolysaccharide, soluble CD14, and intestinal fatty acid‐binding protein
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemokine and cytokine responses of peripheral blood mononuclear cells stimulated with TLR2, 4, or 7/8 agonists
Number of subjects: 0
Study: 20938770

Group type: EXPERIMENTAL
Intervention: Complete supine position
Number of subjects: 33

Group type: COMPARATOR
Intervention: Prone position
Number of subjects: 33
Study: 19781316

Group type: EXPERIMENTAL
Intervention: upstream tirofiban
Number of subjects: 160

Group type: COMPARATOR
Intervention: downstream tirofiban
Number of subjects: 160
Study: 17206703

Group type: EXPERIMENTAL
Intervention: 5 mg/kg infliximab (IFX)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 3-dose IFX induction at weeks 0, 2, and 6
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Infliximab (IFX)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Infliximab (IFX) for acute steroid-refractory colitis
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Age of patients
Number of subjects: 100
Study: 14739846

Group type: EXPERIMENTAL
Intervention: DPRHP
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: P-JS
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control
Number of subjects: 57
Study: 11238498

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (80-microg patches) + oral norethisterone (1 mg daily)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 9755259

Group type: EXPERIMENTAL
Intervention: xylitol syrup
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: xylitol chewing gum
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: xylitol lozenge
Number of subjects: 857

Group type: COMPARATOR
Intervention: control syrup
Number of subjects: 857

Group type: COMPARATOR
Intervention: control chewing gum
Number of subjects: 857

Group type: COMPARATOR
Intervention: control lozenge
Number of subjects: 857
Study: 7851110

Group type: EXPERIMENTAL
Intervention: Mantel‐Haenszel (MH) method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maximum likelihood (MLE) method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observed to expected ratio (O/E) method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 3245292

Group type: EXPERIMENTAL
Intervention: Concentrated human diploid cell vaccine (HDCV) with human rabies immune globulin (HRIG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concentrated and purified human diploid cell vaccine (HDCV) with human rabies immune globulin (HRIG)
Number of subjects: 0
Study: 29466682

Group type: EXPERIMENTAL
Intervention: Acute hypoxia (fraction of inspired oxygen = 0.12)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normoxia (ambient air)
Number of subjects: 10
Study: 27007272

Group type: EXPERIMENTAL
Intervention: Intraperitoneal ropivacaine irrigation
Number of subjects: 110

Group type: COMPARATOR
Intervention: Intraperitoneal normal saline irrigation
Number of subjects: 110
Study: 25151541

Group type: EXPERIMENTAL
Intervention: Natural oil-based emulsion containing allantoin (cream 1)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Aqueous cream (cream 2)
Number of subjects: 174
Study: 22507631

Group type: EXPERIMENTAL
Intervention: 3mg melatonin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 20033409

Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (10 mg/kg/die for 3 days, then 2.5 mg/kg/die)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-dose methylprednisolone (1 mg/kg/die for 3 days, then 2.5 mg/kg/die)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-dose methylprednisolone
Number of subjects: 60
Study: 18165082

Group type: EXPERIMENTAL
Intervention: Topical diclofenac 0.1%
Number of subjects: 142

Group type: COMPARATOR
Intervention: Topical betamethasone 0.1%
Number of subjects: 142
Study: 15679716

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (BUD) 800 mug daily for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12903699

Group type: EXPERIMENTAL
Intervention: Maternity support binder worn while awake for 2 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison group (no binder for 2 weeks)
Number of subjects: 40
Study: 10336792

Group type: EXPERIMENTAL
Intervention: Alprazolam 0.75 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Alprazolam (0, 0.25, 0.50, 0.75 mg)
Number of subjects: 19
Study: 9136458

Group type: EXPERIMENTAL
Intervention: Accelerated fractionation
Number of subjects: 105

Group type: COMPARATOR
Intervention: Conventional fractionation
Number of subjects: 105
Study: 1951401

Group type: EXPERIMENTAL
Intervention: Nebulizer Chronolog (electronic recording device)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-reporting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Canister weighing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Informed participants using the Nebulizer Chronolog
Number of subjects: 0
Study: 6894819

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Azidocillin
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Pivampicillin
Number of subjects: 175
Study: 31187282

Group type: EXPERIMENTAL
Intervention: High‐intensity interval training (HIIT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Moderate‐intensity training (CONT)
Number of subjects: 20
Study: 27578365

Group type: EXPERIMENTAL
Intervention: Esketamine (Ketanest S®) administered intravenously during a 55 min resting-state fMRI scan
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 27639637

Group type: EXPERIMENTAL
Intervention: Gauze impregnated in epinephrine
Number of subjects: 99

Group type: COMPARATOR
Intervention: Aluminum chloride
Number of subjects: 99
Study: 24943252

Group type: EXPERIMENTAL
Intervention: Adaptive Iterative Dose Reduction (AIDR) 3D
Number of subjects: 200

Group type: COMPARATOR
Intervention: Filtered Back Projection (FBP)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Wide-detector technique with AIDR 3D
Number of subjects: 200

Group type: COMPARATOR
Intervention: Helical technique with AIDR 3D
Number of subjects: 200
Study: 22987083

Group type: EXPERIMENTAL
Intervention: Patupilone (10 mg/m² intravenously every 3 weeks)
Number of subjects: 829

Group type: COMPARATOR
Intervention: Pegylated liposomal doxorubicin (PLD) (50 mg/m² intravenously every 4 weeks)
Number of subjects: 829

Group type: EXPERIMENTAL
Intervention: Patupilone
Number of subjects: 829

Group type: COMPARATOR
Intervention: PLD
Number of subjects: 829
Study: 21246846

Group type: EXPERIMENTAL
Intervention: Abdominal acupuncture plus Long's bone-setting manipulation (combined therapy)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Long's bone-setting manipulation (bone-setting group)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Abdominal acupuncture (abdominal acupuncture group)
Number of subjects: 180
Study: 18378456

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control
Number of subjects: 33
Study: 15719319

Group type: EXPERIMENTAL
Intervention: Bilateral superior oblique palsy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unilateral superior oblique palsy
Number of subjects: 20
Study: 12887127

Group type: EXPERIMENTAL
Intervention: HRT (0.625 mg of conjugated equine estrogen combined with 2.5 mg of medroxyprogesterone acetate) for 12 months in HT-HRT group
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: HRT (0.625 mg of conjugated equine estrogen combined with 2.5 mg of medroxyprogesterone acetate) for 12 months in NT-HRT group
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no HRT) in HT-Control group
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no HRT) in NT-Control group
Number of subjects: 97
Study: 10365610

Group type: EXPERIMENTAL
Intervention: Mivacurium (0.25 mg/kg; 3 x SD95)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Succinylcholine (1 mg/kg)
Number of subjects: 82
Study: 8724880

Group type: EXPERIMENTAL
Intervention: Total gastrectomy or Billroth II gastric resection
Number of subjects: 21

Group type: COMPARATOR
Intervention: Cholecystectomy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Total gastrectomy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Gastric resection
Number of subjects: 21
Study: 8370422

Group type: EXPERIMENTAL
Intervention: NOP regimen (mitoxantrone 16 mg/m2, vincristine 2 mg, prednisolone 250 mg day 1-4 and 17-20)
Number of subjects: 151

Group type: COMPARATOR
Intervention: M+P regimen (melphalan 0.25 mg/kg and prednisolone 100-200 mg/day day 1-4)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: NOP regimen
Number of subjects: 151

Group type: COMPARATOR
Intervention: M+P regimen
Number of subjects: 151
Study: 3530633

Group type: EXPERIMENTAL
Intervention: Copper T 220 C
Number of subjects: 200

Group type: COMPARATOR
Intervention: Alza T IPCS 52
Number of subjects: 200
Study: 31823654

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NAC) with nivolumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NAC) with nivolumab and linrodostat mesylate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postsurgery nivolumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postsurgery nivolumab with linrodostat
Number of subjects: 0
Study: 30189846

Group type: EXPERIMENTAL
Intervention: Nurse-based primary care intervention (Guided Care model)
Number of subjects: 1218

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1218
Study: 27450438

Group type: EXPERIMENTAL
Intervention: Acute high-intensity exercise (n = 29)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Non-exercise control (n = 29)
Number of subjects: 58
Study: 24449733

Group type: EXPERIMENTAL
Intervention: Simpson biplane method with good image quality
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Teichholz method with poor image quality
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Teichholz method with good image quality
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Eyeball method
Number of subjects: 63
Study: 24188894

Group type: EXPERIMENTAL
Intervention: Anacetrapib
Number of subjects: 1398

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1398
Study: 21800179

Group type: EXPERIMENTAL
Intervention: Consistent condom use with commercial sex partners
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Consistent condom use with girlfriends
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Consistent condom use with other non-commercial partners
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: HIV prevalence
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Syphilis prevalence
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: HSV-2 prevalence
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Overall prevalence for any STI
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Factors associated with HIV/STIs
Number of subjects: 418
Study: 19895770

Group type: EXPERIMENTAL
Intervention: Increased therapist structure during aftercare treatment
Number of subjects: 247
Study: 17255277

Group type: EXPERIMENTAL
Intervention: Epirubicin
Number of subjects: 177

Group type: COMPARATOR
Intervention: Epirubicin + Tamoxifen
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: HAI-2 expression
Number of subjects: 177
Study: 15767638

Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide, cisplatin, and carmustine (HD-CPB) with stem-cell support
Number of subjects: 785

Group type: COMPARATOR
Intervention: Intermediate-dose cyclophosphamide, cisplatin, and carmustine (ID-CPB) with G-CSF support
Number of subjects: 785
Study: 12472325

Group type: EXPERIMENTAL
Intervention: IMPACT intervention (n = 906)
Number of subjects: 1801

Group type: COMPARATOR
Intervention: Usual care (n = 895)
Number of subjects: 1801
Study: 9559801

Group type: EXPERIMENTAL
Intervention: 750 mg levofloxacin
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1 g levofloxacin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8963007

Group type: EXPERIMENTAL
Intervention: Dimethyl ether-propane cryogenic spray (DMEP)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Liquid nitrogen (LN)
Number of subjects: 124
Study: 1858160

Group type: EXPERIMENTAL
Intervention: OKT3 for the first 14 days after OLT with low-dose steroids
Number of subjects: 46

Group type: COMPARATOR
Intervention: Cyclosporine, steroids, and azathioprine
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: OKT3
Number of subjects: 46

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 46
Study: 6133803

Group type: EXPERIMENTAL
Intervention: Timiperone (1.0 mg/tablet, daily dose of 1-3 tablets for the first day, up to 12 tablets for 12 weeks)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Haloperidol (1.5 mg/tablet, daily dose of 1-3 tablets for the first day, up to 12 tablets for 12 weeks)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Timiperone
Number of subjects: 206
Study: 30837255

Group type: EXPERIMENTAL
Intervention: Coaching intervention for the first 6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard care and printed information about healthy lifestyles
Number of subjects: 30
Study: 30101824

Group type: EXPERIMENTAL
Intervention: Ephedrine 10 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Etilefrine 2 mg
Number of subjects: 40
Study: 26806318

Group type: EXPERIMENTAL
Intervention: Video discharge instructions in addition to standard discharge instructions
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard discharge instructions (Control)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Video discharge instructions for caregivers with less than a high school education
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard discharge instructions for caregivers with less than a high school education (Control)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Video discharge instructions for caregivers with more than a high school education
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard discharge instructions for caregivers with more than a high school education (Control)
Number of subjects: 63
Study: 25245954

Group type: EXPERIMENTAL
Intervention: LIFE intervention (28 group sessions over 12 months)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Standard of care control group (two dietitian-led diabetes self-management classes)
Number of subjects: 210
Study: 22527894

Group type: EXPERIMENTAL
Intervention: Hyaluronan-enriched transfer medium (HETM) (0.5 mg/ml hyaluronan)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Control medium (no hyaluronan)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Hyaluronan-enriched transfer medium (HETM)
Number of subjects: 314
Study: 19172627

Group type: EXPERIMENTAL
Intervention: Dex‐P (4 mg/ml) continuously applied for 14 days via a round window catheter
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%) continuously applied for 14 days via a round window catheter
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Dex‐P (4 mg/ml) after 3 months follow-up
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Dex‐P (4 mg/ml)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 23
Study: 18096042

Group type: EXPERIMENTAL
Intervention: Hall Technique PMCs
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control restorations
Number of subjects: 132
Study: 15188897

Group type: EXPERIMENTAL
Intervention: LASEK
Number of subjects: 42

Group type: COMPARATOR
Intervention: PRK
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: LASEK and PRK
Number of subjects: 42
Study: 12420185

Group type: EXPERIMENTAL
Intervention: Tinnitus Retraining Therapy combined with cognitive behavioral group therapy
Number of subjects: 95

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 95

Group type: COMPARATOR
Intervention: Cognitive behavioral group therapy alone
Number of subjects: 95
Study: 9716201

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 36
Study: 7917733

Group type: EXPERIMENTAL
Intervention: Preoperative multimodal analgesia regimen (morphine 0.15 mg kg‐1 i.m., perphenazine 0.03 mg kg‐1 i.m., indomethacin 100 mg rectal suppository)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Preoperative multimodal analgesia regimen
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (midazolam 0.05 mg kg‐1 i.m. and placebo rectal suppository)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (treatment and placebo)
Number of subjects: 30
Study: 2060256

Group type: EXPERIMENTAL
Intervention: Ibuprofen 50 mg
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Ibuprofen 100 mg
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Ibuprofen 100 mg + Caffeine 100 mg
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg + Caffeine 100 mg
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study: 6297368

Group type: EXPERIMENTAL
Intervention: Melphalan treatment for mucinous tumours in Stages Ia and Ib
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Radiotherapy alone for other patients in Stage I and II
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Combination of Melphalan and radiotherapy
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Irradiation alone for well- or moderately differentiated tumours in Stage I or IIa
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Postoperative treatment for well differentiated, early mucinous tumours in Stage Ia
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Aggressive treatment for poorly differentiated tumours in Stages I and II
Number of subjects: 142
Study: 30940012

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham (placebo) stimulation
Number of subjects: 46

Group type: COMPARATOR
Intervention: Both groups (real and sham)
Number of subjects: 46
Study: 29120984

Group type: COMPARATOR
Intervention: Constant load (CT) resistance training
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Pyramid (PR) resistance training
Number of subjects: 33
Study: 26752496

Group type: EXPERIMENTAL
Intervention: Tetra-ataxiometric posturography in patients with migrainous vertigo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tetra-ataxiometric posturography in patients with migraine without aura
Number of subjects: 48
Study: 24570015

Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone 0.15 mg/kg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Saline-only placebo
Number of subjects: 36
Study: 22271004

Group type: EXPERIMENTAL
Intervention: Water MDCT colonography
Number of subjects: 70

Group type: COMPARATOR
Intervention: Air MDCT colonography
Number of subjects: 70
Study: 18853451

Group type: EXPERIMENTAL
Intervention: Narrowband Imaging (NBI) laryngoscope
Number of subjects: 29